dr bennett's semaglutide obesitymedicine #weightloss #glp1 #flourishclinic #retatrutide #semaglutide #tirzepatide #evidencebasedcare #healthinnovation #southafrica #medicalethics #rantover Dr. Catherine Bennet, MD, Chevy

The combination makes sense for a specific subset: patients with significant weight to lose (50 lbs) who are physically active, willing to train consistently, and concerned about preserving muscle mass and metabolic rate during aggressive caloric restriction

however, human studies have not revealed significant abnormalities with first-trimester exposure

If you have severe allergies or sensitivities, it's always a good idea to inform the staff about your dietary needs so they can take necessary precautions

The bodys response to cannabinoids can change with repeated exposure, potentially leading to tolerance or altered hormone levels

Semaglutide is a medication in a class known as GLP-1 receptor agonists

can create a plan thats tailored to your needs